Tiziana Life Sciences Ltd

TLSANASDAQ · USD
1.04USD-0.01 (-0.96%)
112

Tiziana Life Sciences Ltd (TLSA) Wheel Strategy

No qualifying wheel strategy setups were found for TLSA in the prior session.

Read more

Running a TLSA wheel strategy lets you generate consistent premium income on Tiziana Life Sciences Ltd while setting your own entry and exit prices on the underlying. Tiziana Life Sciences Ltd's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TLSA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TLSA wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TLSA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TLSA wheel from a losing one.

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients.

The company was incorporated in 1998 and is headquatered in London, the United Kingdom.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TLSA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TLSA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 23, 2026

Run the Wheel on TLSA With Confidence

Find the best TLSA wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial